Patent ID: 7282198

Claim:
A method of immunotherapy targeted toward stratum corneum chymotryptic enzyme in an individual having prostate cancer, ovarian cancer, breast cancer or colon cancer, comprising the steps of: (a) isolating dendritic cells from said individual; (b) processing and presenting a human stratum corneum chymotryptic enzyme peptide selected from the group consisting of SEQ ID NO: 32, 33, 35, 36, 86 or the human stratum corneum chymotryptic enzyme protein encoded by the DNA of SEQ ID NO: 30 in said dendritic cells; and (c) transferring said dendritic cells back to said individual, wherein said dendritic cells would activate stratum corneum chymotryptic enzyme-specific immune responses in said individual, thereby generating immunotherapy targeted toward stratum corneum chymotryptic enzyme in said individual.